Lensoside Aβ as an Adjuvant to the Anti-Glioma Potential of Sorafenib

Lensoside Aβ as an Adjuvant to the Anti-Glioma Potential of Sorafenib

Aim: The anti-glioma effect of lensoside Aβ alone and in combination with sorafenib (pro-survival Raf kinase inhibitor) was evaluated for the first time in terms of programmed cell death induction in anaplastic astrocytoma and glioblastoma multiforme cell lines as an experimental model. Apoptosis, a...

Full description

Bibliographic Details
Main Authors: Aleksandra Maciejczyk, Justyna Kapral-Piotrowska, Joanna Sumorek-Wiadro, Adrian Zając, Ewa Grela, Rafał Luchowski, Wiesław I. Gruszecki, Marta Kinga Lemieszek, Iwona Wertel, Łukasz Pecio, Jerzy Żuchowski, Krystyna Skalicka-Woźniak, Bożena Pawlikowska-Pawlęga, Monika Hułas-Stasiak, Wojciech Rzeski, Radosław Rola, Joanna Jakubowicz-Gil
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
lensoside Aβ
sorafenib
gliomas
apoptosis
FTIR
FLIM
Online Access:https://www.mdpi.com/2072-6694/13/11/2637

Internet

https://www.mdpi.com/2072-6694/13/11/2637

Similar Items